Back to Search Start Over

PHASE 2 STUDY OF PEVONEDISTAT + AZACITIDINE VERSUS AZACITIDINE IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES/CHRONIC MYELOMONOCYTIC LEUKEMIA OR LOW-BLAST ACUTE MYELOGENOUS LEUKEMIA (NCT02610777)

Authors :
L. Adès
J. Watts
A. Radinoff
M.A. Sangerman
M. Cerrano
P.F. Lopez
J. Zeidner
M.D. Campelo
C. Graux
J. Liesveld
D. Selleslag
N. Tzvetkov
R.J. Fram
D. Zhao
J. Bell
S. Friedlander
D.V. Faller
M.A. Sekeres
Source :
Hematology, Transfusion and Cell Therapy, Vol 42, Iss , Pp 285-286 (2020)
Publication Year :
2020
Publisher :
Elsevier, 2020.

Details

Language :
English
ISSN :
25311379
Volume :
42
Issue :
285-286
Database :
Directory of Open Access Journals
Journal :
Hematology, Transfusion and Cell Therapy
Publication Type :
Academic Journal
Accession number :
edsdoj.54b5b2dd1ba74c09b0d32f702525ae5d
Document Type :
article
Full Text :
https://doi.org/10.1016/j.htct.2020.10.475